Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
With
AccuDial Pharmaceutical, Inc.
Boehringer Ingelheim
McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.
Novartis
Perrigo Company
Procter and Gamble
Reckitt Benckiser LLC
In light of protocol changes required due to methodological and operational issues, including background noise in cough recordings which could impact data interpretation, the study has been terminated.
Age
6–11
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female healthy children ages 6 to under 12 years who are symptomatic with a cough due to a cold or acute URTI characterized by:
Onset of cold/URTI symptoms occurring no more than 10 days prior to Visit 1;
At least 5 coughs during the second 30-minute period of the 60-minute baseline period.
General good health, aside from a common cold, and has no contraindications to the study or rescue medication
You may not be if
Acute, subchronic, or chronic cough due to any other condition other than a common cold
History of clinically significant cardiovascular, pulmonary, hepatic, renal, neurological, hematological, autoimmune, psychiatric, metabolic, gastro-intestinal or endocrine disease
